GSE195663 cisplatin 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE195663_cisplatin_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE195663_cisplatin_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE195663_cisplatin_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE195663_cisplatin_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

small nucleolar RNA host gene 1

Gene

small nucleolar RNA host gene 5

Gene

H3.7 histone (putative)

Gene

RNA polymerase II subunit J3

Gene

metastasis associated lung adenocarcinoma transcript 1

Gene

NBPF member 26

Gene

HOXD antisense growth-associated long non-coding RNA

Gene

small nucleolar RNA host gene 8

Gene

ATPase H+ transporting V1 subunit G2

  • Gene

    H4 clustered histone 15


  • Gene

    small nucleolar RNA host gene 1


  • Gene

    small nucleolar RNA host gene 5


  • Gene

    H3.7 histone (putative)


  • Gene

    RNA polymerase II subunit J3


  • Gene

    metastasis associated lung adenocarcinoma transcript 1



  • Gene

    HOXD antisense growth-associated long non-coding RNA


  • Gene

    small nucleolar RNA host gene 8


  • Gene

    ATPase H+ transporting V1 subunit G2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.